MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Kodu・Aktsiate loetelu・Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc

Suletud

SektorTervishoid

33.26 0.82

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

32.81

Max

33.7

Põhinäitajad
By Trading Economics
Sissetulek	638K -65M
Müük	7.5M 7.5M
Aktsiakasum	-0.83
Kasumimarginaal	-867.293
Töötajad	316
EBITDA	4.1M -73M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+65.81% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. aug 2025

Turustatistika
By TradingEconomics
Turukapital	-344M 2.4B
Eelmine avamishind	32.44
Eelmine sulgemishind	33.26

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

34.81 / 38.24 Toetus ja vastupanu

Xenon Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. juuli 2025, 23:45 UTC

Omandamised, ülevõtmised, äriostud

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

3. juuli 2025, 23:42 UTC

Market Talk

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

3. juuli 2025, 23:41 UTC

Market Talk

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

3. juuli 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. juuli 2025, 23:15 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

3. juuli 2025, 22:59 UTC

Market Talk

Uranium Market About to Enter Lull -- Market Talk

3. juuli 2025, 22:58 UTC

Market Talk

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

3. juuli 2025, 22:47 UTC

Market Talk

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

3. juuli 2025, 22:21 UTC

Tulu

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

3. juuli 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

3. juuli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3. juuli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

3. juuli 2025, 20:41 UTC

Market Talk

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

3. juuli 2025, 20:41 UTC

Market Talk

Global Equities Roundup: Market Talk

3. juuli 2025, 19:28 UTC

Market Talk

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

3. juuli 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

3. juuli 2025, 18:34 UTC

Market Talk

Gold Has Winning Week, But Down Day -- Market Talk

3. juuli 2025, 18:18 UTC

Market Talk

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

3. juuli 2025, 18:06 UTC

Market Talk

Global Equities Roundup: Market Talk

3. juuli 2025, 18:06 UTC

Market Talk

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

3. juuli 2025, 17:27 UTC

Market Talk

U.S. Oil Rig Count Continues to Slide -- Market Talk

3. juuli 2025, 16:55 UTC

Tulu

Travel Stocks Could Offer Investors a Glorious -2-

3. juuli 2025, 16:55 UTC

Tulu

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

3. juuli 2025, 16:20 UTC

Market Talk

Correction to Health Care Roundup: Market Talk

3. juuli 2025, 16:15 UTC

Market Talk

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

3. juuli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3. juuli 2025, 16:05 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. juuli 2025, 16:05 UTC

Market Talk

Gold Futures Fall Following Jobs Report -- Market Talk

3. juuli 2025, 15:47 UTC

Tulu

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

3. juuli 2025, 15:36 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Xenon Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

65.81% tõus

12 kuu keskmine prognoos

Keskmine 55.33 USD 65.81%

Kõrge 65 USD

Madal 47 USD

Põhineb 15 Wall Streeti analüütiku instrumendi Xenon Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

15 ratings

Osta

Hoia

Müü

Põhineb 15 analüütiku instrumendi Xenon Pharmaceuticals Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

34.81 / 38.24Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.